BRC-002

N/A

Report date: 2025/11/06 20:00:17

First In Class

Base Information

Drug NameBRC-002

Drug Alias Namenaturally biosynthesized within the Cannabis sativa L. plant as acidic forms of CBD(University Of California San Diego)High CBD Cannabis Extract (University Of California San Diego)BRC-002

ClassificationNatural product/Extract > Plants extract

Mechanisms of ActionCannabinoid receptor modulators

TargetsCannabinoid receptor

Therapy Area/IndicationsRestless Legs SyndromeComplex Regional Pain Syndromes

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of California San Diego

China Registration ClassN/A

Develop Information

Active CompaniesBiopharmaceutical Research Company University Of California San Diego University Of Colorado Denver

Inactive CompaniesN/A

Active IndicationsRestless Legs SyndromeComplex Regional Pain Syndromes

Inactive IndicationsN/A

Other Information

ATC CodeN/A